Open AccessPleiotropic Effects of Losartan in Hypertensive Patients with Dyslipidemia
Author(s) -
Sivakumar Sivasubramaniam,
Banupriya Kumarasamy
Publication year - 2017
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2017/30909.10638
Subject(s) - dyslipidemia , losartan , medicine , blood pressure , lipid profile , renal function , angiotensin ii , obesity , cholesterol
In essential hypertension, the comorbidity of dyslipidemia is very common. In addition to hypertension, dyslipidemia is linked to cardiovascular disease, stroke and decline in renal function. Unlike other angiotensin receptor blockers, Losartan has been claimed to have unique pleiotropic property and thereby decreasing the risk of future cardiovascular complications.